Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MLCO.CN
SellHot AirThe More Life Company Corp. · Healthcare · Canada · $26M · Avg Vol: $8K/d
23
StockRankGet insider-trade alerts
Q
19
V
23
M
66
P/E (TTM)
—
ROE
—
D/E
—
Dividend %
—
COMPANY DESCRIPTION
The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada.
FINANCIAL SUMMARY (CAD)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | — | 0 | 60.0K | 49.0K | 65.0K | 4.1% | 64.7K |
| EPS (CAD) | — | -0.02 | -0.02 | -0.02 | -0.01 | — | -0.01 |
| Shares | — | 329.7M | 329.7M | 352.4M | 352.4M | +6.9% | 457.0M |
| Debt | 44.0K | 6.0K | 0 | — | 0.4M | 74.0% | 0.4M |
| Equity | — | 16.2M | 8.7M | 2.5M | -0.1M | -60.4% | — |
| Op CF | — | -4.8M | -3.3M | -3.9M | -2.1M | — | -2.5M |
| Inv CF | — | 1.9M | -0.5M | -0.3M | 0.2M | — | — |
| Fin CF | — | -1.6M | 0 | 0 | 0.5M | — | — |
Loading 1Y...
PRICE (1Y)-13.3%
SMA 50SMA 200
Close
$0.047
RSI (14)
55.0
52W High
$0.0759
From 52W High
0.6%
SCORE BREAKDOWN
Quality
19
ROIC
-890.8%0.6
ROE
—N/A
GP/Assets
—N/A
Op. Margin
-2446.2%5.3
FCF/Assets
-403.6%0.2
Piotroski
325.9
Int. Cover
—N/A
D/E Ratio
—N/A
Current Ratio
3.55x60.2
Value
23
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
—N/A
P/S
562.5x3.4
Div Yield
—N/A
Momentum
66
52W High %
62%37.8
RS 6M
324%100.0
SMA 50/200
1.55x98.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$26M
P/E (Forward)
—
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MLCO.CN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MLCO.CN | The More Life Company Corp.(you) | $26M | 23 | Sell |
| VM.V | Voyageur Pharmaceuticals Ltd. | $28M | 19 | Strong Sell |
| LSL.V | LSL Pharma Group Inc. | $30M | 15 | Strong Sell |
| OPTI.CN | Optimi Health Corp. | $27M | 12 | Strong Sell |
| ROMJ.V | Rubicon Organics Inc. | $29M | 53 | Hold |
| NVRS.CN | Noveris Health Sciences Inc. | $55M | 3 | Strong Sell |
| LEEF.CN | Leef Brands Inc. | $58M | 42 | Hold |
| CRDL | Cardiol Therapeutics Inc. | $227M | 23 | Sell |
| DB.V | Decibel Cannabis Company Inc. | $51M | 67 | Buy |
| ACB | Aurora Cannabis Inc. | $254M | 35 | Hold |
Peer medians: ROE -37.9% · P/E 17.3x · Gross margin 44.6%